Abstract 408: Discovery of a first-in-class dual microtubule- and RAF—targeting inhibitor.
Year: 2026
Type: conference-abstract
Source: Cancer Research
Authors: Joshua W. Large, Yeni K. Romero, Kylie Luther, Molly M. Hood, Ranjan Preet, Cale L. Heiniger, Chase K. Crawley, Salim Javed, Yu Mi Ahn, Cynthia B. Leary, Forrrest A. Stanley, Justin T. Proto, Lakshminarayana Vogeti, Bertrand Le Bourdonnec, Bryan D. Smith, Daniel L. Flynn, Jeffery D. Zwicker, Stacie L. Bulfer
Institution: Deciphera Pharmaceuticals (United States)
Language: English
Subfield: Cell Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W7148864701
Cites:
Cited by:
Related to: